3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
Neoplasm Metastasis
9
Neoplasms
8
Brain Neoplasms
5
Ovarian Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Neoplasms by Site
3
Glioma
3
Endometrial Neoplasms
3
Breast Diseases
3
Squamous Cell Carcinoma of Head and Neck
2
Liposarcoma
2
Head and Neck Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasms, Squamous Cell
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Interventions
venetoclax
92
Azacitidine
78
Cytarabine
70
Specimen Handling
47
fludarabine
45
Biopsy
34
Cyclophosphamide
30
Daunorubicin
28
Injections
26
Decitabine
26
fludarabine phosphate
25
Idarubicin
24
Busulfan
20
Whole-Body Irradiation
19
Granulocyte Colony-Stimulating Factor
19
Mycophenolic Acid
18
Tacrolimus
17
Melphalan
17
decitabine and cedazuridine drug combination
16
CPX-351
15
gilteritinib
14
Stem Cell Transplantation
14
Mitoxantrone
13
Peripheral Blood Stem Cell Transplantation
12
Magnetic Resonance Spectroscopy
12
ivosidenib
11
Filgrastim
11
Etoposide
11
Cladribine
11
revumenib
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
abemaciclib
×
90 days
×
Clear all
No trials found.